GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Euroespes SA (XMAD:EEP) » Definitions » Debt-to-Equity

Euroespes (XMAD:EEP) Debt-to-Equity : 0.70 (As of Dec. 2022)


View and export this data going back to 2011. Start your Free Trial

What is Euroespes Debt-to-Equity?

Euroespes's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was €1.77 Mil. Euroespes's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was €2.60 Mil. Euroespes's Total Stockholders Equity for the quarter that ended in Dec. 2022 was €6.20 Mil. Euroespes's debt to equity for the quarter that ended in Dec. 2022 was 0.70.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Euroespes's Debt-to-Equity or its related term are showing as below:

XMAD:EEP's Debt-to-Equity is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.23
* Ranked among companies with meaningful Debt-to-Equity only.

Euroespes Debt-to-Equity Historical Data

The historical data trend for Euroespes's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Euroespes Debt-to-Equity Chart

Euroespes Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.40 0.47 0.49 0.54 0.70

Euroespes Semi-Annual Data
Dec12 Jun13 Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.60 0.54 0.66 0.70

Competitive Comparison of Euroespes's Debt-to-Equity

For the Diagnostics & Research subindustry, Euroespes's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Euroespes's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Euroespes's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Euroespes's Debt-to-Equity falls into.



Euroespes Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Euroespes's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Euroespes's Debt to Equity Ratio for the quarter that ended in Dec. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Euroespes  (XMAD:EEP) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Euroespes Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Euroespes's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Euroespes (XMAD:EEP) Business Description

Traded in Other Exchanges
N/A
Address
Santa Marta de Babio, Bergondo, La Coruna, ESP, 15165
Euroespes SA is a biomedical research center offering medical, research, medical informatics and bioinformatics services. It offers medicine and personalized treatment for central nervous system disorders and researches genomic medicine. Other services offered by the company include genomics, digital diagnosis, diagnostic imaging, neuro-psychology, neuro-ophthalmology, nursing, epigenetics, clinical analysis and otorhinolaryngology.